BPA Scrutiny

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org

2 posts / 0 new
Last post
Amanda Hurst
Amanda Hurst's picture
Offline
Last seen: 1 year 2 months ago
Joined: 04/22/2023 - 05:57
BPA Scrutiny

Our institution is currently in a season of incredibly high scrutiny on BPAs (including non-provider BPAs and those that would be 100% actionable). I am curious if others are experiencing this same thing, and if so, have you developed specific criteria to meet in order to recommend a BPA and/or a flowsheet when assessing whether or not a BPA is the best way to incorporate a safety measure. We are an Epic institution.

Thanks!
Amanda Hurst, PharmD, BCPPS
Sanford Medical Center

Tags: